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The scaffold-forming steps of plant alkaloid
biosynthesis
Benjamin R. Lichman *
Alkaloids from plants are characterised by structural diversity and bioactivity, and maintain a privileged
position in both modern and traditional medicines. In recent years, there have been significant advances
in elucidating the biosynthetic origins of plant alkaloids. In this review, I will describe the progress made
in determining the metabolic origins of the so-called true alkaloids, specialised metabolites derived from
amino acids containing a nitrogen heterocycle. By identifying key biosynthetic steps that feature in the
majority of pathways, I highlight the key roles played by modifications to primary metabolism, iminium
reactivity and spontaneous reactions in the molecular and evolutionary origins of these pathways.
1. Introduction
1.1. Background
1.2. Denition of alkaloids
1.3. Major alkaloid classes












3.1.1. N-Methylaminobutanal and N-methylpyrrolinium
3.1.2. 5-Aminopentanal and D1-piperideine
3.1.3. 4-(4-Oxobutylamino)butanal and pyrrolizidine


































Alkaloids from plants have remarkable powers to harm, heal
and reveal; this has led to their use in herbal medicine and
related practises across continents and cultures for millennia.
Alkaloids were foundational in the development of organic
chemistry and were among the rst pharmaceuticals developed.
They retain a privileged position in modern medicine, used
widely to treat pain, cancer, dementia and countless other
ailments (Fig. 1).1,2 Despite losing pace to synthetic drug
discovery approaches in recent decades, plant alkaloids remain
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a viable source of bioactive compounds with considerable
therapeutic potential.3
It is only through the elucidation of plant alkaloid biosyn-
thesis—determining chemical intermediates, characterising
enzymes and sequencing genomes—that we can truly appre-
ciate and understand the synthetic ingenuity of nature in con-
structing these complex compounds. There has been
remarkable progress in the discovery and characterisation of
enzymes over the last decade, triggered by advances and
expanded use of sequencing technologies.4,5 Genome assem-
blies of alkaloid producing plants have revealed certain
biosynthetic genes co-localise in clusters, aiding gene discovery
and providing insight into evolution and pathway regulation.6–8
The investigation of plant alkaloid biosynthesis can lead to
new tools and technologies. For example, enzymes can be
employed as biocatalysts for the in vitro formation of new-to-
nature compounds.9,10 Genes and pathways can be heterolo-
gously expressed in genetically tractable and rapidly growing
organisms in an attempt to increase alkaloid yield, purity or
access new-to-nature compounds through pathway modica-
tions.11–13 Understanding the genomic basis for alkaloid
biosynthesis can also inform efforts to breed plants with higher
compound yields or lower toxicity.14
1.2. Denition of alkaloids
Alkaloids were originally dened as alkaline substances
extracted from a plant with a biological activity.15 This de-
nition has been rened multiple times to include compounds
from outside the plant kingdom, as well as those that share
a biosynthetic origin with alkaloids but do not have a basic
nitrogen.16,17 In the broadest sense, alkaloids are nitrogen-
containing compounds derived from secondary, or speci-
alised, metabolism. However, it is useful to categorise alka-
loids further, not with the intention of excluding
compounds, but to help comprehend similarities and
differences in the compounds' origins (Fig. 2). The true
alkaloids, referred to as complex alkaloids in this review, are
compounds in which the nitrogen atom is derived from an
amino acid and is part of a heterocycle. Proto-alkaloids, or
simple alkaloids, are amines derived from amino acids but
do not have a nitrogen heterocycle. Pseudo-alkaloids are
nitrogen-containing metabolites in which the nitrogen is
introduced at a late stage through an enzymatic process such
as transamination.
1.3. Major alkaloid classes
This review focusses on complex ‘true’ alkaloids from plants:
compounds derived from an amino acid containing
a nitrogen heterocycle. Despite their wide structural diversity
Fig. 2 Types of alkaloids. Sparteine and quinine are true alkaloids,
derived from lysine and tryptophan respectively. Mescaline is a proto-
alkaloid. Coniine and aconitine are pseudo-alkaloids, with the nitrogen
inserted through transamination.
Fig. 1 Examples of pharmaceutical alkaloids.
Dr Benjamin Lichman received
his MSc in Natural Sciences from
the University of Cambridge and
his PhD in biochemistry from
University College London. His
doctoral research, under the
guidance of Professors John Ward
and Helen Hailes, focussed on
the mechanism and applications
of norcoclaurine synthase. He
then joined the group of Prof
Sarah O'Connor at the John Innes
Centre to investigate iridoid
biosynthesis in plants. In 2018 he was appointed a lecturer at the
Centre for Novel Agricultural Products at the University of York.
Benjamin is currently a UKRI Future Leaders Fellow and manages
a research group investigating the origins and applications of plant
natural product biosynthesis.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































and taxonomic distribution, the biosynthetic origins of these
compounds follows a unifying chemical logic centred around
the formation and reactivity of the iminium cation.18 I will
examine the rst steps of alkaloid biosynthetic pathways: the
transition from primary to specialised metabolism and
formation of the dening scaffold. The metabolic, enzymatic
and evolutionary origins of these steps will be reviewed,
including the latest developments in the eld.
This review will cover all major complex alkaloid families in
plants. Compounds derived from tyrosine include benzyliso-
quinolines, tetrahydroisoquinolines and the Amaryllidaceae
alkaloids. Although not classically described as alkaloids, the
tyrosine-derived betalains share many biosynthetic features
with alkaloids and will be discussed. The tryptophan-derived
monoterpene indole alkaloids are included. The anthranilate
derived acridone and quinoline alkaloids are only briey
mentioned, as they do not subscribe to the biosynthetic
patterns described in this review. Polyamine derived alkaloids
including piperideine, tropane, quinolizidine, pyrrolizidine and
Nicotiana alkaloids are all included. It is hoped that the
principles of biosynthesis discussed in this review can be
applied to many alkaloid families not directly mentioned.
1.4. Patterns in biosynthesis
The rst steps in an alkaloid pathway are the most crucial,
acting as the gateway to a new chemical space. They are
important metabolically, as they direct ux away from primary
and into specialised metabolism. They are signicant chemi-
cally and enzymatically as they involve the formation of a new
molecular structure. They also play a foundational role in the
evolution of the pathways.
There are four steps that are typically present in the rst steps
of complex alkaloid biosynthesis: (i) accumulation of an amine
precursor, (ii) accumulation of an aldehyde precursor, (iii)
formation of an iminium cation and (iv) a Mannich-like reaction
(Scheme 1). This nal step is oen considered the “scaffold-
forming”, signature, or rst-committed step into a pathway.
A major origin of variation in these generalised steps is
whether they are intermolecular or intramolecular (Table 1). For
example, polyamine-derived alkaloids generally form a cyclic
Scheme 1 Themes in complex alkaloid biosynthesis explored in this review.
Table 1 Origins of major alkaloid subtypes. Italic text refers to specific compounds or reaction types within the general categories
Alkaloid type Amine origin Aldehyde origin Iminium Mannich-like reaction
Nicotine Polyamine, putrescine Intramolecular Cyclic iminium, pyrollinium Intermolecular, nicotinic acid
Tropane Polyamine, putrescine Intramolecular Cyclic iminium, pyrollinium Intermolecular, polyketide
Lycopodium Polyamine, cadaverine Intramolecular Cyclic iminium, piperideine Intermolecular, polyketide
Quinolizidine Polyamine, cadaverine Intramolecular Cyclic iminium, piperideine Intermolecular, dimerization
Pyrrolizidine Polyamine,
homospermidine
Intramolecular Cyclic iminium, pyrollinium Intramolecular
Betalains Tyrosine, L-DOPA Tyrosine,
betalamic acid
Intermolecular, spontaneous None





Tryptophan, tryptamine Terpene, secologanin Intermolecular,
enzyme catalysed
Intramolecular, Pictet–Spengler
Amaryllidaceae Tyrosine, tyramine Phenylpropanoid,
benzaldehyde
Intermolecular Intramolecular, reduction
Ipecac Tyrosine, dopamine Terpene, secologanin Intermolecular Intramolecular, Pictet–Spengler
Colchicine Tyrosine, dopamine Phenylpropanoid,
dihydrocinnamaldehyde
Intermolecular Intramolecular, Pictet–Spengler
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































iminium through intramolecular condensation, followed by an
intermolecular Mannich-like reaction. In contrast, the Pictet–
Spengler step that contributes to major alkaloid families, such
as the benzylisoquinolines, is an intermolecular condensation,
involving formation of an iminium intermediate, followed
immediately by an intramolecular Mannich-like reaction.
There have been many excellent general reviews of alka-
loids,16,17,19 and many detailed reviews of individual alkaloid
families.14,20–34 In order to differentiate this review, and to
highlight its focus on the patterns in the early steps of biosyn-
thesis, it will not be structured by alkaloid class but instead by
the particular step in the aforementioned biosynthetic model
(Scheme 1). By viewing alkaloid biosynthesis in this holistic
manner, it may be possible to gain insights from one pathway
that can be applied to aid elucidation of another.
2. Amine accumulation
The nitrogen in complex alkaloids originates from amino acid
metabolism. The majority of alkaloids do not directly
incorporate an amino acid, but instead use a primary amine
derivative. Simple primary amines are ubiquitous in green
plants, and have a variety of both essential and specialised roles
in development, reproduction and stress responses.35–38 In the
general pattern of alkaloid biosynthesis proposed in this review,
amines accumulate beyond typical concentrations to enable
ux to be directed into alkaloid metabolism without disruption
to existing pathways. This usually requires changes to metabo-
lism bought about by gene duplication. The contribution of
primary metabolism to plant chemical diversity has been
recently reviewed.39
For essential or abundant amines, such as putrescine or
tyramine, accumulation may result from higher expression or
duplication of a pre-existing gene without modication to the
enzyme's substrate scope. Accumulation of amines that are
typically at low concentrations or absent, such as cadaverine or
homospermidine, may require the evolution of new enzyme
activity through modication of substrate scope.40 Other
possible routes to the accumulation of amines include boosting
the concentration of amino acid precursors, or reducing
degradative catabolic pathways. The amines contributing to
alkaloid biosynthesis can be split into two categories: poly-
amines, derived from lysine, arginine and ornithine; and
aromatic amines, derived from tryptophan and tyrosine.
2.1. Polyamines
The polyamines putrescine, spermine and spermidine play
essential roles in plants, for example in seed development41 and
protein translation35,42,43 (Fig. 3). Cadaverine is found only in
selected plant taxa (e.g. legumes) and contributes to stress
responses.44 The simple polyamines putrescine and cadaverine
are precursors to major alkaloid classes containing pyrrolinium
or piperideine moieties respectively. The triamine dimer of
putrescine, homospermidine, is a precursor to the pyrrolizidine
alkaloids.
Fig. 3 Polyamines in plants. Putrescine, spermidine and spermine are
ubiquitous in green plants whereas cadaverine and homospermidine
only accumulate in selected taxa.
Scheme 2 Putrescine derived alkaloids. (A) Putrescine derived alkaloids (moiety originating from putrescine highlighted in blue). (B) Biosynthesis
of putrescine from ornithine or arginine.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































2.1.1. Putrescine. Putrescine is incorporated into alkaloids
via the intermediate N-methylpyrrolinium (Scheme 2A). In
plants, putrescine can be derived from arginine or ornithine
(Scheme 2B). Ornithine decarboxylation is the typical route in
eukaryotes.43 Ornithine decarboxylases (OrnDCs) have been
identied and characterised from nicotine45 and tropane alka-
loid46,47 producing plants. An alternative route to putrescine
proceeds via arginine. In some plants, such as Arabidopsis,
OrnDC is absent and the arginine pathway is the sole route to
putrescine.48 The arginine pathway starts with decarboxylation
of arginine catalysed by arginine decarboxylase,47,48 and appears
to have been derived from the endosymbiont precursor to the
chloroplast.49,50
The nightshade family (Solanaceae) includes species rich in
putrescine-derived alkaloids, such as Nicotiana tobaccum
(nicotine) and tropane alkaloid producers Atropa belladonna
and Solanum sp. In this family, the ornithine pathway appears
to be the major source of putrescine for alkaloid biosyn-
thesis.51,52 A number of Solanaceae species contain two copies of
OrnDC, originating from a putative duplication event prior to
the emergence of the family.53 In Nicotiana, one OrnDC co-
expresses with alkaloid biosynthesis genes in the roots.53 The
duplication of OrnDC may have led to tissue specic accumu-
lation of putrescine, ultimately enabling the formation of
diverse putrescine-derived alkaloids in Solanaceous plants.
2.1.2. Cadaverine. Cadaverine is a precursor to the piper-
ideine moiety that is incorporated into alkaloids including the
granatane, lycopodium and quinolizidine families (Scheme 3A).
Cadaverine is derived from lysine by decarboxylation (Scheme
3B). Bifunctional lysine/ornithine-decarboxylases (Lys/OrnDCs)
have been characterised from quinolizidine and lycopodium
alkaloid producers.54,55 Lys/OrnDCs are homologous to OrnDCs,
but demonstrate enhanced lysine decarboxylase activity. The
switch from an OrnDC to a bifunctional Lys/OrnDC appears to
have occurred independently at least twice: within the legumes
(Fabaceae), preceding the origin of quinolizidine alkaloid
biosynthesis, and in the lycophyte lineage, preceding the origin
Scheme 4 Homospermidine derived alkaloids. (A) Homospermidine and a derived pyrrolizidine alkaloid (moiety derived from homospermidine,
the necine base, highlighted in blue). (B) Biosynthetic route to homospermidine from putrescine (Ad ¼ adenosyl). (C) Activity of deoxyhypusine
synthase. Protein represents eIF5A precursor.
Scheme 3 Cadaverine derived alkaloids. (A) Cadaverine derived alka-
loids (portion originating from cadaverine highlighted in blue).
Huperzine A labelling based on predicted biosynthetic pathway.57 (B)
Biosynthesis of cadaverine from lysine.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































of the lycopodium alkaloid pathway.55,56 Both shis in activity
occurred with a substitution from histidine-344 to tyrosine or
phenylalanine, enhancing activity with lysine.54,55 Plants with
Lys/OrnDC do not appear to retain a separate OrnDC paralog,
indicating gene duplication of OrnDC is not necessary for the
emergence of Lys/OrnDCs. This may be because Lys/OrnDCs
maintain sufficient OrnDC activity, or because the alternative
arginine pathway fulls the plants' requirement for putrescine.
2.1.3. Homospermidine. The pyrrolizidine alkaloids are
toxic alkaloids present in multiple families including Apoc-
ynaceae, Asteraceae and Boraginaceae.28,58 The core pyrrolizi-
dine moiety (also known as the necine base) is derived from
homospermidine (Scheme 4A), which is formed from putres-
cine and spermidine in a reaction catalysed by homo-
spermidine synthase (Scheme 4B). Spermidine is essential for
normal plant growth,35,59 and is formed by spermidine synthase
from the substrates putrescine and S-adenosyl-
methioninamine, a decarboxylated form of the co-factor S-
adenosyl methionine (SAM).
Homospermidine synthase (HSS) has evolved from deoxy-
hypusine synthase (DHS) on at least six independent occa-
sions.42,58,60,61 Deoxyhypusine synthase has a key role in
eukaryotic translation, modifying the initiation factor eIF5A
with an aminobutyl group derived from spermidine (Scheme
4C). It is also able to accept putrescine as a substrate in place of
eIF5A. Duplications and neofunctionalisations have led to
enhancement of putrescine activity and reduction of eIF5A
activity to yield HSS.61 Convergence is also evident on the
residue level, with identical active site substitutions occurring
in each independent HSS origins.62
2.2. Aromatic amines
The aromatic amino acids tyrosine and tryptophan are precur-
sors to major alkaloid families, typically via their primary amine
derivatives, tyramine and tryptamine. Simple tyramine and
tryptamine-derived products are ubiquitous in green plants
(Fig. 4). For example, tyramine contributes to the structure of
suberin, a cell wall biopolymer,37 and hordenine, found in
barley, is a derivative of tyramine with anti-fungal properties.38
Tryptophan contributes to a number of simple proto-alkaloids
in plants via indole including indole-3-acetic acid and the
indigo precursor indican. Tryptamine is a precursor to sero-
tonin and psychoactive proto-alkaloids such as
dimethyltryptamine.36
Tyramine and tryptamine are derived from tyrosine and
tryptophan by decarboxylation, catalysed respectively by tyro-
sine decarboxylase (TyrDC)63 and tryptophan decarboxylase
(TrpDC).64,65 These decarboxylases are ubiquitous in green
Scheme 5 Tyrosine derived alkaloids. Portion from tyrosine highlighted in blue.
Fig. 4 Examples of simple aromatic amines in plants derived from tyrosine and tryptophan.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































plants: TyrDCs and TrpDCs form distinct clades in the plant
aromatic amino acid decarboxylase (AAAD) protein family; both
appear to have originated in the angiosperm ancestor.66 Despite
their evolutionary distance, they share active site and substrate
recognition sites: substitution of a single residue in Papaver
somniferum TyrDC with the equivalent amino acid from
Catharanthus roseus TrpDC (S372G) enables TyrDC to accept
indolic substrates, and the complementary mutation in
CrTrpDC has the equivalent effect, allowing it to accept
phenolic substrates.67
2.2.1. Tyrosine. Tyrosine is the precursor to multiple alka-
loid families including the benzylisoquinolines (BIA), the
Amaryllidaceae alkaloids and the betalains. A TyrDC from
Amaryllidaceae alkaloids biosynthesis has recently been
discovered and enables incorporation of tyramine into the
structures.68 Many alkaloids are derived from dopamine, for
example the BIAs and alkaloids from Colchicaceae, Erythrina
and ipecac (Carapichea ipecacuanha) (Scheme 5). Dopamine can
be formed from tyrosine through two steps, hydroxylation and
decarboxylation (Scheme 6).24 Two TyrDCs were identied in the
Scheme 7 Tryptophan derived alkaloids. (A) Origin of tryptamine from tryptophan. (B) Alkaloids derived from tryptamine. Portion from tryp-
tophan highlighted in blue.
Scheme 6 Origins of tyrosine derived alkaloids. Biosynthesis of dopamine has not been elucidated outside of betalain producing plants. Tyrosine
hydroxylase and DOPA oxidase have only been described in betalain biosynthesis. Arogenate dehydrogenase is typically inhibited by tyrosine, but
in betalain producing plants a second arogenate dehydrogenase is present lacking sensitivity to tyrosine.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































BIA producing Papaver somniferum, both able catalyse decar-
boxylation of L-DOPA and L-tyrosine, with a slight preference in
vitro for L-DOPA.69–71 However, the BIA associated enzyme cata-
lysing the hydroxylation step remains unknown. The 3-hydroxy
group introduced by this missing hydroxylase is essential for
downstream Pictet–Spengler reactions (see Section 5.2).72,73
In the BIA producing Papaver species, dopamine accumulates
to a high concentration (16% cellular dry weight of P. bracteatum)
and is stored in the vacuole.74,75 Tyramine accumulates up to 5mM
in the latex of a low-alkaloid variety of P. somniferum.76 These
observations indicate that tyrosine derived amines accumulate in
BIA producing plants; however, the metabolic and evolutionary
origins of this accumulation remain unclear.
By contrast, the metabolic and evolutionary origins of tyro-
sine accumulation in betalain producing plants is well charac-
terised. Betalain pigments are derived from tyrosine, but unlike
typical alkaline alkaloids, they incorporate amino acids directly
without decarboxylation. The non-proteinogenic amino acids L-
DOPA and cyclo-DOPA are precursors to betalains, and are
formed through hydroxylation and oxidative cyclisation of
tyrosine catalysed by cytochrome P450s in the CYP76AD1-
subfamily.77 The hydroxylation is equivalent to the missing step
in BIA dopamine biosynthesis. The CYP76AD1-subfamily in the
betalain producing Caryophyllales form two clades,78 with
enzymes in the b-clade (CYP76AD5/6/15) catalysing the
hydroxylation of tyrosine,79,80 and enzymes in the a-clade
(CYP76AD1-4) capable of catalysing both tyrosine hydroxylation
and L-DOPA oxidative cyclisation to form cyclo-DOPA.79–82 As
betacyanins are derived from cyclo-DOPA whereas betaxanthins
are not, the ratio of a- and b-clade enzymes can determine the
ratio of betaxanthins and betacyanins (see Section 4.2.2).83
The metabolic origins of the betalain pathway lie in primary
metabolism and tyrosine biosynthesis.84 Arogenate dehydroge-
nases (AroDH) catalyse the formation of tyrosine and typically
have strong product feedback inhibition.85 In the Car-
yophyllales, there are two clades of AroDH paralogs: AroDHbs,
which have the typical tyrosine sensitivity, and AroDHas, which
show relaxed sensitivity to tyrosine. These two clades emerged
in the ancestor of the core Caryophyllales, prior to the emer-
gence of betalain biosynthesis: AroDHas may cause accumula-
tion of tyrosine required for betalain biosynthesis. This shows
how changes in primary metabolism resulting in the
Scheme 9 Metabolite fate of putrescine. Typically, putrescine is converted to GABA and shuttled into the citric acid cycle. In plants producing
putrescine-derived alkaloids, a portion of putrescine is shuttled into alkaloid biosynthesis through methylation and oxidation.
Scheme 8 Biosynthetic origins of acridone and quinoline alkaloids. Anthrinilate synthase is typically inhibited by tryptophan, but in acridone/
quinoline alkaloid producing plants a second anthrinilate synthase is present lacking sensitivity to tryptophan.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































accumulation of metabolites may have led to the evolution of
new pathways.
2.2.2. Tryptophan. Tryptamine, the amine derivative of
tryptophan, is a precursor to b-carboline alkaloids including the
harmala alkaloids, nigakinone, and, most notably, the mono-
terpene indole alkaloids (MIA) (Scheme 7).86 MIA producing
species in the Gentianales order, including Catharanthus roseus,
appear to have a single copy of TrpDC.64,87,88 However, the
camptothecin producing Camptotheca acuminata (Cornales) has
two copies of TrpDC, one of which is regulated developmentally
and the other which is elicited by stress responses;89 this
duplication may have contributed to the accumulation of
tryptamine in this species.
The acridone and quinoline alkaloids, derived from the
tryptophan precursor anthranilate, do not follow the typical
alkaloid biosynthetic pattern described in this review.90
However, their origins are informative regarding how precur-
sors can accumulate (Scheme 8). Anthranilate is formed from
chorismate through a reaction catalysed by anthranilate syn-
thase (AS), which is typically feedback inhibited by tryptophan,
enabling regulation of the tryptophan accumulation.91 The
acridone alkaloid producing species Ruta graveolens has two
copies of the ASa subunit: ASa2 is constituently expressed and
inhibited by tryptophan, whereas ASa1 is upregulated upon
elicitation and has reduced sensitivity to tryptophan.92,93 ASa1
enables the accumulation of anthranilate that ultimately leads
to increased alkaloid biosynthesis.
2.3. Summary
The nitrogen atom denes alkaloids. Therefore understanding
how nitrogen is channelled into alkaloid biosynthesis is vital for
our comprehension of their metabolic and evolutionary origins.
Many of the amine precursors of complex alkaloids are present
in the majority of plant taxa. Modications to the metabolism of
these precursors can result in their accumulation and chan-
nelling into alkaloid biosynthesis. In both betalain and acri-
done biosynthesis core metabolic enzymes have been
duplicated, and their feedback inhibition reduced, enabling
accumulation of precursors.84,93 In the Solanaceae, duplication
of OrnDC may have led to the accumulation of putrescine.53
In pathways where the amine precursor is not part of primary
metabolism, enzyme evolution has occurred. This includes the
repeated evolution of HSS from DHS in pyrrolizidine alkaloid
biosynthesis,58 and of Lys/OrnDC from OrnDC for piperideine
alkaloid formation.55 These events have happened multiple
times independently due to the inherent promiscuity of the
ancestral enzymes.
Does accumulation of amine precursors presage alkaloid
evolution? Or does modication to primary metabolism serve to
push ux through a pre-existing pathway? Phylogenetic anal-
yses of genes involved in the formation of amine precursors in
betalain (AroDH), piperideine (Lys/OrnDC) and pyrrolinium
biosynthesis (OrnDC) place enzyme duplication/evolution
events prior to the emergence of alkaloid producing taxa.53,55,84
Whilst further verication is needed of this chronology, it
suggests that amine accumulation pregures the emergence of
alkaloid biosynthesis.
3. Aldehyde accumulation
Complex alkaloid biosynthesis typically requires an aldehyde
precursor. The aldehyde must accumulate to a high concen-
tration and in close proximity to the amine precursor to enable
the next stage of general alkaloid biosynthesis, formation of
a reactive iminium intermediate. For polyamine-derived alka-
loids, this aldehyde is formed through oxidative deamination of
a terminal amine on the polyamine precursor, forming an
amino aldehyde. In aromatic amine derived alkaloids, the
aldehyde moiety is present on a distinct molecule, typically
a secondary metabolite.
3.1. Amino aldehydes
The oxidative deamination of a primary amine on a polyamine
produces an amino aldehyde. As described below (Section 4.1),
this leads to the spontaneous intramolecular formation of
a cyclic iminium, which is a key electrophilic intermediate in
alkaloid biosynthesis. The catabolism of polyamines in primary
metabolism involves oxidative deamination catalysed by
copper-containing amine oxidases (CuAOs) or FAD-dependent
polyamine oxidases.94 The enzymes responsible for aldehyde
formation in polyamine derived alkaloid biosynthesis appears
to have been derived from these catabolic enzymes.95
3.1.1. N-Methylaminobutanal and N-methylpyrrolinium.
Alkaloids derived from putrescine proceed via the cyclic
Scheme 10 Polyamine oxidation steps. (A) Oxidative deamination of cadaverine to 1-piperidiene. (B) Putative double deamination of homo-
spermidine in pyrrolizidine alkaloid formation.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































iminium precursor N-methylpyrrolinium. This is derived from
putrescine via a methylation to N-methylputrescine, catalysed
by putrescine N-methyltransferase (PMT),96 and oxidative
deamination, catalysed by N-methylputrescine oxidase (MPO)
(Scheme 9).97,98 The product, N-methylaminobutanal, sponta-
neously condenses to form N-methylpyrrolinium. The biosyn-
thesis of N-methylpyrrolinium has been investigated primarily
in the Solanaceae (e.g. Nicotiana),22,53 though the taxonomic
distribution of N-methylpyrrolinium alkaloids indicates there
are multiple independently evolved pathways.99
PMTs are SAM-dependent methyltransferases that evolved
from spermidine synthases (SPDSs).100,101 Wild-type SPDSs
demonstrate PMT activity, indicating that neofunctionalisation
of SPDS to PMT can occur with ease.101 The PMT involved in
tropane and nicotine biosynthesis emerged from a SPDS
duplication in the Solanales lineage, prior to the origin of the
Solanaceae.53,101
MPO is a copper-containing amine oxidase localised to the
peroxisome.95 The Solanaceae MPO originated from a CuAO
homolog generated by a whole genome triplication event.53,95 As
part of polyamine catabolism, peroxisomal CuAOs oxidise
putrescine to 4-aminobutanal, which is then directed into the
TCA cycle via 4-aminobutyrate and succinate (Scheme 9).102,103 It
is possible that the methyl group introduced by PMT prevents
recognition by catabolic enzymes, allowing N-methyl-
aminobutanal to accumulate.
3.1.2. 5-Aminopentanal and D1-piperideine. Oxidative
deamination and cyclisation of cadaverine yields 5-amino-
pentanal which cyclises into D1-piperideine (Scheme 10A).
CuAOs catalysing the formation of D1-piperideine from cadav-
erine have been identied in the lycopodium alkaloid
producing Huperzia serrata104 and quinolizidine alkaloid accu-
mulating narrow leafed lupin (Lupinus angustifolius).105 Unlike
putrescine, cadaverine does not play a role in primary metab-
olism and therefore to accumulate it may not have to bypass
catabolic processes.
3.1.3. 4-(4-Oxobutylamino)butanal and pyrrolizidine. Two
oxidative deamination steps are required to form the pyrrolizi-
dine moiety from the triamine homospermidine (Scheme 10B).
Homospermidine is converted into the dialdehyde 4-(4-oxobu-
tylamino)butanal prior to cyclisation into pyrrolizidine. In pyr-
rolizidine alkaloid producing Boraginaceae species, an
inhibitor for CuAOs impeded pyrrolizidine formation and
caused an increase in homospermidine content, indicating
a CuAO catalyses the putative homospermidine oxidase step.106
However, this key enzyme has not been identied in any pyr-
rolizidine alkaloid pathway.
3.2. Amino acid origins
Aldehydes that are incorporated into amino-acid derived alka-
loids accumulate independently of the amine precursor. Oen,
the aldehyde is a specialised metabolite, already present at high
Scheme 12 Biosynthesis of betalamic acid.
Scheme 11 Biosynthesis of 4-hydroxyphenylacetaldehyde and its incorporation into benzylisoquinoline alkaloids.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































concentration. Alternatively, aldehyde accumulation could be
triggered by gene duplications or other changes to metabolism.
3.2.1. Phenylacetaldehydes. BIAs are formed from dopa-
mine and 4-hydroxyphenylacetaldehyde (4-HPAA), both deriva-
tives of tyrosine.23 Recently, a deviation to this route has been
found: Macleaya cordata appears to form BIAs via 3,4-dihy-
droxyphenylacetaldehyde and not 4-HPAA.107 4-HPAA biosyn-
thesis requires two steps from tyrosine, transamination and
decarboxylation (Scheme 11). A tyrosine aminotransferase from
Papaver somniferum was found to generate 4-hydrox-
yphenylpyruvate,108 but the enzyme catalysing the following
decarboxylation is unknown. Multiple aromatic acetaldehyde
synthases (AASs) catalysing the formation of aldehydes from
aromatic amino acids have been identied in plants,66,109
including an 4-HPAA synthase from salidroside biosynthesis in
Rhodiola rosea.63 AASs have evolved convergently from decar-
boxylases in the PLP-dependent L-amino acid decarboxylase
(AAAD) family and represent an alternative candidate for this
elusive step in BIA producing species.66 It is noteworthy that in
BIA biosynthesis, both amine and aldehyde are derived from
tyrosine—this points to the pathway emerging in a tyrosine-rich
context.
3.2.2. Betalamic acid. The formation of betalamic acid,
the aldehyde of the betalain pathway, is catalysed by the
enzyme 3,4-dihydroxyphenylalanine 4,5-dioxygenase (DODA)
(Scheme 12). DODA is a 2-oxoglutate dependent oxygenase
enzyme in the LigB family that catalyses the 4,5-extradiol
cleavage of L-DOPA.110,111 This reaction reveals a reactive seco
intermediate that spontaneously cyclises to form betalamic
acid.112 All known highly active DODA enzymes are in the
Scheme 14 Biosynthesis of dihydrocinnamaldehydes.
Scheme 13 Substituted benzaldehyde biosynthesis. Pathway to vanillin from Vanilla planifolia.116 Coumaroyl ester hydroxylation may occur on
CoA or Sh/Q ester. Sh ¼ shikimate, Q ¼ quinate.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































Caryophyllales DODA a-clade, which split from the non-
active b-clade prior to the formation of betalain pigmenta-
tion.78 Various lineages of the DODA a-clade then duplicated
and acquired high DODA activity through convergent evolu-
tion.31 Seven amino acid residues have been identied that
are sufficient to switch a marginally active DODAa into an
active DODAa,113 and there is evidence that the polyphyletic
highly active DODAs converged on similar residues at these
key positions.114 Analysis of DODA indicates multiple origins
of betalain pigmentation in the Caryophyllales, within
a context where L-DOPA was accumulating and a DODAa
enzyme with low but notable activity was present. As
described above (Section 2.2.1), duplication of AroDH led to
high tyrosine levels in Caryophyllales. This, in turn, may have
enabled generation and accumulation of betalamic acid.
3.3. Phenylpropanoids
3.3.1. Benzaldehydes. Substituted benzaldehydes are
products of the phenylalanine derived phenylpropanoid
pathway. Benzaldehydes contribute to the Amaryllidaceae
alkaloids,26,27 and the cryptostylines (Cryptostylis fulva).115 The
aldehyde precursor to the Amaryllidaceae alkaloids is 3,4-dihy-
drobenzaldehyde. The biosynthesis of this compound has not
been elucidated, but it appears analogous to the biosynthesis of
vanillin (Scheme 13).116 Notably, Amaryllidaceae, Cryptostylis
and Vanilla are part of the monocot Asparagales order, so may
contain homologous benzaldehyde biosynthesis pathways and
enzymes.
3.3.2. Dihydrocinnamaldehyes. The phenylpropanoid
pathway is a likely origin of the aldehydes required to form
phenyl-ethylisoquinolines such as those in Cephalotaxus,
Schelhammera and Colchicum. The aldehydes contributing to
these pathways are likely to be substituted dihy-
drocinnamaldehydes,117–119 which can be derived from
substituted cinnamic acid, by reduction of both the a,b double-
bond and carboxylic acid (Scheme 14). The double bond
reduction may occur on the CoA-ester bound form of the acid120
or the free aldehyde.121
3.4. Secologanin
Iridoids are a widespread class of secondary metabolites derived
from the monoterpene pathway.122 Within the plant kingdom,
iridoids are largely restricted to the Asterids,123 where they
typically occur as glycosides providing chemical defence against
biting herbivores.124 Seco-iridoids, such as secologanin, are
a subset of iridoids where the 5-membered carbon ring has
been oxidatively cleaved. These seco-iridoids are found in
multiple plants where alkaloids are absent.125,126 In C. roseus
(Gentianales), secologanin is the precursor to all monoterpene
indole alkaloids (MIAs). It is also a precursor to the ipecac
Scheme 15 Iridoid monoterpene derived alkaloids. (A) Iridoid secologanin/secologanic acid and derived alkaloids. Strictosidine/strictosidinic
acid derived from trypamine (blue). Ipecac alkaloids derived from dopamine (red). (B) Biosynthesis of secologanin/secologanic acid.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































alkaloids (Carapichea ipecacuanha [Gentianales] and Alangium
salviifolium [Cornales]) (Scheme 15A).127–129
The iridoid biosynthetic pathway has been elucidated in C.
roseus, and derives from geraniol (Scheme 15B).122 Secologanin
is formed from loganin through the action of secologanin syn-
thase (SLS, CYP72A1).130 SLS is closely related to another
enzyme involved in iridoid biosynthesis, 7-deoxyloganic acid
hydroxylase (CYP72A224), indicating that substrate recognition
is key to CYP evolution.131 C. roseus contains at least two copies
of SLS.132
The MIA pathway in Camptotheca acuminata (Cornales)
proceeds via secologanic acid and not secologanin.133 Conse-
quently, strictosidinic acid and not strictosidine is the rst MIA.
Cytochrome P450s (CYP72A565 and CYP72A610) from C. acu-
minata are able to catalyse both the hydroxylation 7-deoxy-
loganic acid to form loganic acid and the oxidative cleavage of
loganic acid to form secologanic acid.134 These are closely
related to secologanin synthase (CYP72A1) and 7-deoxyloganic
acid hydroxylase (CYP72A224).
Nothapodytes nimmoniana (Icacinales) also produces camp-
tothecin, though is more closely related to Gentianales than
Cornales, and the pathway appears to proceed using the typical
Gentianales route via secologanin.135 Icaninales and Gentia-
nales may share an MIA origin, and this is supported by char-
acterisation of an active secologanin synthase from N.
nimmoniana (NnCYP72A1).136
4. Iminium formation
A primary amine can condense reversibly with an aldehyde to
form an electrophilic iminium cation, also known as a Schiff
base (Scheme 16). In water, the equilibrium is typically on the
side of the reactants, and the concentration of iminium ions is
low.137–139 The position of the equilibrium can shi towards the
products if the iminium is cyclic or conjugated.140,141
Surprisingly, the ratio of neutral imine to charged iminium
in solution is largely dependent on the pKaH of the amine
precursor (9–10), rather than the pKaH of the iminium itself
(7), meaning that at physiologically relevant pHs the reactive
iminium will be more abundant than the imine.137 Iminiums
are highly electrophilic and form rapidly, so even when they not
at high concentrations, the product of their reaction with
a nucleophile can accumulate, provided the reaction is irre-
versible. This reaction of an iminium with a nucleophile is
described here as a Mannich-like reaction, which quenches the
reactivity of both the iminium and nucleophile.
Enzyme catalysed formation of iminiums is oen futile due
to their high reactivity in water: no enzymes catalysing only
iminium formation have been described. However, iminiums
can be enzyme substrates, such as in imine reductases, which
typically take preformed iminiums (typically conjugated or
cyclic) from solution as substrates.140 Yet, iminium formation
can be enzyme catalysed when coupled directly to a quenching
reaction, such as reduction.142
4.1. Intramolecular
The electrophilic intermediates in polyamine derived alkaloid
biosynthesis are cyclic iminiums such as N-methylpyrollinium
and D1-piperideine, formed from linear amino aldehydes
through intramolecular condensation (Scheme 17). These rings
form spontaneously, without the requirement for catalysis, as
demonstrated by chemical syntheses.143,144 Even in water, the
cyclic iminium will be abundant. The CuAO enzymes forming
the amino aldehyde are localised to the peroxisome, and the
cyclic iminiums will form upon ejection into the solvent or
possibly in the enzyme active site.95,105
4.2. Intermolecular
In the biosynthesis of alkaloids derived from aromatic amines,
the iminium intermediate is formed through an intermolecular
condensation and is non-cyclic. Typically, these iminiums are at
very low concentration in water. This potentially unfavourable
equilibrium can be overcome through rapid quenching of the
transient iminium through an intramolecular nucleophile, as
seen in Pictet–Spengler reactions (see Section 5.2); or through
formation of a highly stable conjugated iminium as demon-
strated in betalain biosynthesis (Section 4.2.2).
4.2.1. Coupled reactions. In Pictet–Spengler reactions, the
scaffold-forming step in the BIA and MIA biosynthetic path-
ways, the reversible formation of the electrophilic iminium is
followed by an irreversible rate-determining intramolecular
electrophilic aromatic substitution (Section 5.2).145,146 This
essentially couples iminium formation and a Mannich-like
reaction; the iminium exists as a transient intermediate.
Enzymes catalysing the Pictet–Spengler reactions, norco-
claurine synthase (NCS) and strictosidine synthase (STS),
appear to catalyse iminium formation as part of their mech-
anism.146,147 However, they may also be able to accept pre-
Scheme 17 Polyamine-derived alkaloid formation. Cyclic iminium
formation is followed by a Mannich-like reaction.Scheme 16 Mechanism of iminium formation.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































formed iminiums, as demonstrated by their ability to bind
secondary amine mimics of reaction intermediates.148,149 In
Amaryllidaceae alkaloid biosynthesis, the iminium interme-
diate, norcraugosodine, is conjugated, giving it greater
stability in aqueous conditions (Fig. 5).27,141 The enzyme cat-
alysing the subsequent reduction step has not yet been char-
acterised so the nature of enzyme involvement in iminium
formation remains unknown. In any reaction requiring
intermolecular iminium formation, co-localisation of amine
and aldehyde is required. Further details about Pictet–Spen-
glerases, norbelladine synthase and co-localisation of
substrates is discussed in Section 5.2.
4.2.2. Stable iminium. Betalain biosynthesis is unique
amongst all the alkaloids described here as it lacks a Mannich-
like step. Instead, the iminium formed from condensation of
betalamic acid and an amine/amino acid is stable in water and
can accumulate. Iminium stability is conferred by the highly
conjugated structure, which also endows the molecules with
their pigmentation properties (Scheme 18).
Betalains are all derived from the aldehyde containing
betalamic acid, but can be divided into two categories
depending on the amine donor: the red betacyanins are derived
from cyclo-DOPA, and the yellow betaxanthins are derived from
amino acids or other amines (e.g. dopamine, tyramine) (Scheme
18). The iminium formation step appears to occur spontane-
ously and does not require enzyme catalysis.150 The specic
betalain formed therefore appears to depend on the concen-
trations of amines present. For example, in plants expressing
betalain biosynthesis genes heterologously, the ratio of beta-
cyanins and betaxanthins can be controlled solely by varying the
amount of the L-DOPA oxidase activity present (see Section
2.2.1). This enzyme forms cyclo-DOPA, and its presence
enhances betacyanins at the expense of betaxanthins.83
Like many other pigments, betalains are stored in the
vacuole. However, the key enzymes required for cyclo-DOPA and
betalamic acid biosynthesis are cytoplasmic.151 Neither the
subcellular location nor control mechanisms of iminium
condensation have been determined. The vacuole represents
Scheme 18 Betalain biosynthesis. Iminium formation steps are spontaneous without requiring enzyme catalysis.
Fig. 5 Stability of iminium intermediates. Predicted trend in iminium intermediates in alkaloid biosynthesis based on conjugation.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































one possible location for iminium formation: the reaction may
be promoted in acidic conditions, and betalain selectivity could
be controlled by the accumulation of specic amines by tono-
plast (vacuolar) transporters. Identication and character-
isation of tonoplast transporters in betalain producers would
help resolve this question.
5. Mannich-like reaction
The key step in many alkaloid biosynthetic pathways is a Man-
nich-like reaction, in which the iminium reacts irreversibly with
a nucleophile. This reaction quenches reactive species and
causes the formation of a new carbon–carbon bond; it is
therefore very energetically favourable, to the extent that in
many cases the reaction can proceed without enzyme catalysis.
This reaction can be considered the rst committed step into an
alkaloid pathway, as the specic combination of electrophile and
nucleophile denes alkaloid subtype and is irreversible. Further-
more, it is typically the scaffold-forming step and establishes
a heterocyclic structure that is central to alkaloid identity, with
impacts on downstream reactions and compound bioactivities.
5.1. Polyamine-derived
In polyamine-derived alkaloids, the Mannich-like reaction is
typically intermolecular. The nucleophiles are of diverse origin
and give rise to specic alkaloid sub-types. These nucleophiles
must accumulate in the same subcellular location as the imi-
nium. As the accumulating non-amine component of the
alkaloid, they are equivalent to aldehydes required in aromatic
amino acid derived alkaloids.
To date, no enzymes have been described that catalyse the
intermolecular Mannich-like reactions of alkaloid biosynthesis,
and it is possible that the in planta reactions occur spontane-
ously with no enzyme catalysis. The intermolecular nature of
the reaction has led to a modular organisation of in polyamine
alkaloid biosynthesis, where a range of different nucleophiles
may combine with either N-methylpyrollinium or D1-piper-
ideine to generate chemical diversity.
5.1.1. Polyketide. The best understood Mannich-like reac-
tion in polyamine-derived alkaloid biosynthesis is from tropane
alkaloid biosynthesis in the Solanaceae (Scheme 19A). N-
Methylpyrollinium is attacked by an enol form of 3-oxoglutaric
acid, a nucleophile derived from polyketide biosynthesis.
Recently, the enzymes that are required to form the character-
istic seven-membered tropane ring have been described.152–154
Pyrrolidine ketide synthase (PYKS), a type III polyketide
synthase, catalyses the formation of 3-oxoglutaric acid from two
malonyl-CoA units. PYKS has an active site with the typical type-
III PKS catalytic triad for substrate loading and chain extension
(Cys166, His305 and Asn338), but has additional residues (Arg-
134 and Ser-340) which limit the enzyme to a single extension
step by interacting with the substrate carboxylate moiety.153
When incubated with PYKS, N-methylpyrollinium and
malonyl-CoA form 4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoic
acid, a key intermediate.152,153 PYKS forms 3-oxoglutaric acid
from malonyl-CoA and releases it into the solvent where it
Scheme 19 Tropane alkaloid biosynthesis. (A) Outline of tropane alkaloid biosynthesis as elucidated in Solanaceae. Methyltransferase step in
Erythroxylum is hypothetical. (B) Hypothetical mechanism of tropinone synthase. Note that a methylester would not decarboxylate, giving rise to
methylecgonone.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































spontaneously reacts with N-methylpyrollinium through
a decarboxylative Mannich condensation.153 PYKS does not
utilise N-methylpyrollinium as a starter unit, nor does the
enzyme catalyse the condensation reaction. This observation is
supported by the racemic nature of 4-(1-methyl-2-pyrrolidinyl)-
3-oxobutanoic acid, and by the presence of the side products
hygrine and cuscohygrine, which may be formed through
decarboxylation or a second decarboxylative Mannich conden-
sation respectively.153
The 4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoic acid interme-
diate can be converted to tropinone through the action of tro-
pinone synthase (CYP82M3).152 The mechanism of this is
unknown, but a possible route is formation of a pyrollinium
cation through hydroxylation and dehydration (Scheme 19B).
This intermediate then undergoes a further, possibly sponta-
neous, intramolecular decarboxylative Mannich condensation
to yield tropinone.
Tropane alkaloids emerged independently Erythroxylaceae
and Solanaceae.99 However, in Erythroxylum coca (Erythrox-
ylaceae) alkaloids, the tropane ring has an additional carbox-
ymethyl group. This could arise if the carboxylic acid moiety of
4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoic acid is methylated
prior to cyclisation (Scheme 19).152 The enzymes catalysing the
formation of tropane alkaloids in the Erythroxylaceae are yet to
be fully described.155
The solution of the key step in tropane biosynthesis has
implications for other pathways. The 3-oxoglutaric acid nucle-
ophile can also react with D1-piperideine, leading to a set of
homologous compounds and pathways to those derived from N-
methylpyrollinium. For example, quenching of D1-piperideine
by 3-oxoglutaric acid through a decarboxylative Mannich reac-
tion yields oxo-2-piperidine-butanoic acid. This intermediate
could decarboxylate to yield pelletierine, a homolog of hygrine,
or undergo oxidative cyclisation to yield norpseudopelletierine,
a homolog of tropinone (Scheme 20A).22,153 Pseudopelletierine is
a precursor to the granatane alkaloids. The biosynthesis of
lycopodium alkaloids such as huperzine is likely to proceed via
aldol addition of oxo-2-piperidine-butanoic acid to pelletierine
(Scheme 20B).57,156
5.1.2. Nicotiana. Alkaloid biosynthesis in Nicotiana has
a modular arrangement: a single nicotinic acid-like nucleophile
can quench N-methylpyrollinium to form nicotine, or D1-
piperideine to form anabasine (Scheme 21A). The nicotinic
acid-like nucleophile is derived from a nicotinamide co-factor-
like pathway that emerged from gene duplications in the Nico-
tiana lineage (aer the split of Solanum). Interestingly, these
gene duplications were coupled with duplication of transcrip-
tion factors and changes to transcription-factor binding sites in
genes, ultimately leading to root-specic expression of the
nicotine biosynthetic pathway.53
Scheme 20 Hypothesised formation of piperideine alkaloids. (A) Proposed formation of piperideine derived alkaloids based on known formation
of tropane alkaloids. (B) Possible route to lycopodium alkaloids such as huperzine.57
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































A gene encoding an NADPH-dependent reductase, A622, has
a major role in activating nicotinic acid, however neither the
substrate nor product structure is known.157,158 It is hypoth-
esised that the nucleophilic compound attacking N-methylpyr-
ollinium or D1-piperideine may be 3,6-dihydronicotinic acid or
3,6-dihydropyridine (Scheme 21B).159
The nal step in nicotine biosynthesis is catalysed by vacu-
olar located avin-containing oxidases with similarity to
berberine-bridge enzymes (BBLs).160 Knocking out all six BBL
paralogs in tobacco results in a nicotine-free plant.161 Knocking-
down BBL expression results in the accumulation of a reduced
nicotine metabolite (dihydrometanicotine), indicating that the
enzyme acts aer the condensation step, oxidising the pyridine
ring (Scheme 21B).19,160 A similar oxidation is likely to be
involved in anabasine production.
It is possible that, like the quenching step in tropane alka-
loid biosynthesis, the reaction between N-methylpyrollinium or
D1-piperideine and the nicotinic acid derivative is spontaneous.
This is supported by the observation that the enantiomeric
excess of the (S)-enantiomer in natural nicotine is caused by
enantioselective enzymatic demethylation of (R)-nicotine to (R)-
nornicotine and not selective cyclisation.162 The increase in
anabasine to nicotine ratio through increased concentration of
precursors could also be indication of this.163 Based on the
location of BBL it is possible the Mannich-like reaction occurs
in the vacuole.
5.1.3. Dimerisation. In the scaffold-forming steps of qui-
nolizidine alkaloid biosynthesis, both the nucleophile and
electrophile are derived from D1-piperideine. The dimerization
between the two monomers requires an imine-enamine tauto-
merisation followed by Mannich condensation (Scheme 22A).
No enzymes catalysing these reactions have been described. In
solution, D1-piperideine interconverts betweenmultiple species
at different pHs, including a-tripiperideine and the hydro-
anabasine dimer (Scheme 22B).143,164 In plants, quinolizidines
do not always co-occur with D1-piperideine derived alkaloids,
indicating that dimerization of D1-piperideine must be suffi-
ciently slow to allow quenching by other nucleophiles.
Density functional theory calculations indicate that the
dimerization reaction between D1-piperideine and 2-piper-
ideine occurs spontaneously to form the (R,R) or (S,S)-tetrahy-
droanabasine, but formation of the (R,S)- or (S,R)-
Scheme 22 Quinolizidine alkaloid biosynthesis. (A) Dimerisation of D1-piperideine. (B) Behaviour of D1-piperideine in solution.143 (C) Hypo-
thetical origin of ()-lupinine from energetically viable piperideine dimer precursor.
Scheme 21 Nicotine biosynthesis. (A) Origins of nicotine and anabasine. (B) Putative biosynthetic pathway for nicotine.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































tetrahydroanabasine dimers proceeds more slowly.165 The dia-
stereoselectivity of the spontaneous reaction matches the
biosynthetic origins of compounds such as ()-lupinine,
a major alkaloid found in Lupinus (Scheme 22C).32 However,
quinolizidines are oen found in high enantiomeric excess,
suggesting that a stereoselective enzyme catalyses the dimer-
ization step, or downstream enzymes exert enantioselectivity.
5.1.4. Pyrrolizidine formation. The scaffold-forming step of
pyrrolizidine alkaloid biosynthesis is unusual in the context of
polyamine derived alkaloid biosynthesis in that the Mannich-
like reaction is intramolecular (Scheme 23A). This reaction
can occur spontaneously and stereoselectively in acidic condi-
tions to yield the trans-product (Scheme 23B).144 In plants, pyr-
rolizidines typically accumulate as single enantiomers.
Furthermore, pyrrolizidines with cis-stereochemistry are
common (e.g. nervosines, Scheme 23C).28 These factors point to
an enzyme controlled intramolecular Mannich condensation.
Alternatively, there may be selective degradation of isomers.
Due to the inherent reactivity of the dialdehyde, the enzyme that
catalyses oxidative deamination may also control the subse-
quent stereoselective cyclisation.
5.2. Aromatic amino-acid derived
Major classes of alkaloids generated from aromatic amines
proceed via a Pictet–Spengler reaction. In this reaction, the
intermolecular condensation of an amine and aldehyde forms
an iminium, which is then quenched through intramolecular
electrophilic aromatic substitution.166,167 The tethered nucleo-
philic aromatic system bypasses the requirement for accumu-
lation of a distinct nucleophile. Mechanistic and biocatalytic
aspects of Pictet–Spenglerases have been reviewed recently.10
The entry to the tyramine derived Amaryllidaceae alkaloids does
not involve a Pictet–Spengler reaction; instead, the Mannich-
like step is a reduction, in which the hydride can be consid-
ered an intermolecular nucleophile.
5.2.1. Tetrahydroisoquinolines. The Pictet–Spengler reac-
tion between dopamine and an aldehyde yields a tetrahy-
droisoquinoline, and can proceed in aqueous conditions,
catalysed by acid168 or inorganic phosphate.72 Key to the facile
nature of this reaction is the dopamine 3-hydroxyl group, which
increases the nucleophilicity of the catechol ring and directs the
substitution to the 6-position (Scheme 24A). As the reaction has
a low energy barrier, the presence of tetrahydroisoquinoline
Scheme 24 Formation of tetrahydroisoquinolines. (A) General formation of tetrahydroisoquinolines from dopamine and an aldehyde. (B)
Reaction catalysed by norcoclaurine synthase. (C) Mechanism of norcoclaurine synathase.
Scheme 23 Pyrrolizidine alkaloid biosynthesis. (A) Proposed route from homospermidine to pyrrolizidine base precursor. (B) Biomimetic
synthesis of trachelanthamidine from Takano et al. 1981.144 C. Structure of nervosine VII, a cis-pyrrolizidine.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































metabolites are no guarantee of a Pictet–Spenglerase catalyst.169
However, Pictet–Spenglerases may serve to increase the rate of
reaction, provide substrate selectivity or determine
stereoselectivity.
In benzylisoquinoline alkaloid biosynthesis, norcoclaurine
synthase (NCS) catalyses the Pictet–Spengler condensation
between dopamine and 4-HPAA, yielding (S)-norcoclaurine
(Scheme 24B).170–173 NCS is a member of the pathogenesis-
related 10/Bet-v1 (PR10) protein family, a diverse set of small
(15–25 kDa), soluble proteins notable for their ability to bind
diverse ligands.172,174 NCSs from Ranunculaceae (e.g. Thalictrum
avum) are single domain proteins, but NCS from the Papa-
veraceae, which includes opium poppy (P. somniferum), are
present as fused repeats, with up to four consecutive domains
on the same polypeptide chain.175 Recently, two more PR10s
involved in BIA biosynthesis have been identied: thebaine
synthase176 and neopinone isomerase.177 Outside BIA metabo-
lism, PR10s have roles in defence responses178 and binding
intermediates in secondary metabolism pathways.179,180
NCS contains an N-terminal signal peptide, which targets the
enzyme to the vacuole via the endoplasmic reticulum.172 As
previously described, the vacuole may be a site with high
dopamine concentrations.75 However, it has been proposed that
the primary site of NCS activity is en route to the vacuole, in the
lumen of the endoplasmic reticulum, possibly in alkaloid
specic vesicles.23,181 The details of subcellular trafficking in BIA
biosynthesis including the primary location of NCS activity has
not yet been resolved.
The mechanism of NCS (Scheme 24C) has been elucidated
through structural182,183 and computational analyses.147 Dopa-
mine binds in the enzyme active site prior to 4-HPAA, with the
catechol 3-OH H-bonding to the Lys-122 residue deep in the
active site and the residues Glu-110 and Asp-141 interact with
the dopamine amine group.148 Iminium formation probably
involves acid/base catalysis from Glu-110 and Asp-141, and may
also involve changes to the enzyme structure.183 The key steps of
C–C bond formation and subsequent loss of proton are cata-
lysed by Lys-122 and Glu-110 respectively.
To date, all characterised NCS enzymes are from Ranunculales.
The control of the Pictet–Spengler reaction in BIA biosynthesis
outside this order, such as in sacred lotus (Nelumbo nucifera, Pro-
teales) or themagnoliids, is unknown. NCS activity was found to be
widely distributed in plant extracts from across angiosperms,
including those not producing BIAs, but the proteins responsible
for this were not identied.171 A number of NCS homologs are
present in the sacred lotus genome and some feature some key
NCS catalytic residues; however, these have not been charac-
terised.184 Phylogenetic analysis of NCSs across published genomes
place these lotus sequences away from the NCS clade indicating an
independent origin of BIAs in lotus.185 Sacred lotus produces BIAs
with both (S)- and (R)-stereoisomers,186 suggesting that: (i) both (S)-
and (R)-selective NCSs are present, (ii) there is an epimerisation
step in the pathway or (iii) the Pictet–Spengler reaction is not
enzyme catalysed.
The species Alangium salviifolium (syn. A. lanmarckii, Cor-
naceae) and Carapichea ipecacuanha (syn. Psychotria ipecacu-
anha, Cephaelis ipecacuanha, Rubiaceae) produce alkaloids
derived from the Pictet–Spengler condensation of dopamine
and secologanin (Scheme 25A). Despite similarities in the
biosynthetic pathways, the species' evolutionary distance
suggests they were acquired independently. A. salviifolium cell-
free extract catalyses the condensation of dopamine and seco-
loganin into both epimer products: (1R)-deacetylipecoside and
(1S)-deacetylisoipecoside.187 An enzyme with stereoselective
(1R)-deacetylipecoside synthase activity was partially puried
from A. salviifolium, though no sequence information was
Scheme 25 Alkaloids derived from dopamine. (A) Alkaloids derived from dopamine and secologanin. Emetine is found in C. ipecacuanha and is
derived from a second Pictet–Spengler reaction. (B) Alkaloids derived from dopamine and dihydrocinnamaldehyde. (C) Alkaloids derived from
dopamine and substituted benzaldehyde.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































determined.129 In alkaloid biosynthesis in ipecac (C. ipecacu-
anha), both (1R)-deacetylipecoside and (1S)-deacetylisoipeco-
side are intermediates with separate metabolic fates, though
enzymes catalysing their formation are not known.127,188 The
ipecac alkaloid emetine is formed through a second Pictet–
Spengler condensation.
There are multiple examples of alkaloids derived from
dopamine and dihydrocinnamaldehyde derivatives, such as
those found in the Colchicaceae (e.g. Colchicum, Schelhammera)
and Cephalotaxus (Scheme 25B).20,119 Cryptostylines (Cryptosty-
lis) are products of Pictet–Spengler condensation of dopamine
and benzaldehydes (Scheme 25C). To date, no enzymes have
been reported catalysing the Pictet–Spengler step in these
pathways.
5.2.2. b-Carbolines. The rst committed step into the MIA
pathway is the stereoselective Pictet–Spengler condensation of
tyramine and secologanin, forming a(S)-strictosidine, and cat-
alysed by strictosidine synthase (SS) (Scheme 26).189 Key resi-
dues in Rauvola serpentina SS are His-307, which binds the
secologanin sugar moiety, and Glu-309 which catalyzes the rate-
limiting rearomatization step.146 The substrates bind indepen-
dently and in random order.
Strictosidine synthases are part of the nucleophilic attack
six-bladed b-propeller (N6P) superfamily, which includes
enzymes such as paraoxonases and lactonohydrolases, and
likely evolved from metal dependent enzymes.190,191 Strictosi-
dine synthase-like (SSL) proteins are ubiquitous in plants, and
although their activities are largely unknown, they appear to
have diverse functions including in anther development192 and
defence response.193
In plants, SS is localised to the vacuole of laticifer cells.194,195
However, the enzymes involved in the formation of its
substrates, tryptophan decarboxylase and secologanin syn-
thase, are in the cytoplasm and endoplasmic reticulum
respectively. Strictosidine glucosidase, the enzyme that converts
strictosidine into reactive aldehyde intermediates, is localised
to the nucleus.196 Therefore, transportation of substrates and
products are necessary. The efflux of strictosidine across the
vacuolar membrane (tonoplast) is controlled by CrNPF2.9,
a member of the nitrate/peptide transporter family (NPF).197 The
transporters involved in the vacuolar import of tryptamine and
secologanin are unknown.
Strictosidine synthase (SS) has so far only been characterised
from Gentianales. In MIA biosynthesis in Camptotheca acumi-
nata (Cornales), the precursor to MIAs is 3-(S)-strictosidinic
acid,133 but a putative strictosidinic acid synthase has not been
identied, and there is no clear ortholog to SS in the tran-
scriptome or genome.198 Based on the substrates employed, it is
possible that the MIA pathways in Camptotheca and the Gen-
tianales are convergent, and if so, the Pictet–Spenglerase is
unlikely to be orthologous to SS. In contrast, MIA biosynthesis
in Nothapodytes nimmoniana (Icaninales) and Gentianales are
likely to share a common origin,136 and accordingly a putative
strictosidine synthase homologous to those in Gentianales has
been identied in its transcriptome.199
The Harmala alkaloids (Peganum harmala) may be derived
from a Pictet–Spengler condensation of a tryptophan-derived
amine with pyruvate. However, few details of the biosynthesis
have been elucidated.200
5.2.3. Reduction. The rst committed step into the Amar-
yllidaceae alkaloids (AA) is the condensation of trypamine and
3,4-dihydroxbenzaldehyde to form the imine norcraugosodine,
followed by reduction to yield norbelladine (Scheme 27A). The
reduction step is likely to be catalysed by an NAD(P)H depen-
dent dehydrogenase/reductase. Within the general scheme of
alkaloid biosynthesis, hydride can be considered an intermo-
lecular nucleophile quenching the electrophilic iminium. AAs
are therefore unique amongst alkaloid pathways in requiring
intermolecular reactions for both iminium formation and
quenching. It is possible that this enzyme may also catalyse the
formation of norcraugosodine, though the conjugated iminium
may be sufficiently stable to reach appreciable levels in solution
(see Section 4.2.1).141
An NADPH-dependent short chain reductase from N. pseu-
donarcissus capable of catalysing the formation of norbelladine
from trypamine and 3,4-dihydroxbenzaldehyde has been re-
ported.201 However, this enzyme was characterised as norox-
omaritidine reductase, as this activity was 400 faster than the
nobelladine synthase activity (Scheme 27B). The low norbella-
dine synthase activity indicates this is a side reaction and
unlikely to be relevant in planta. However, the result shows in
principle that norbelladine can be formed by a reductase
incubated with tyramine and 3,4-dihydroxybenzaldehyde.
Scheme 26 Strictosidine synthase reaction.
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































Surprisingly, a homolog of norcoclaurine synthase (NCS),
has been proposed to catalyse the formation of norbelladine
from tyramine and 3,4-dihydrobenzaldehyde.202 Whilst it is
conceivable that an NCS-type enzyme could aid in iminium
formation, it is unlikely to catalyse the subsequent reduction
step. Therefore, the key step in AA biosynthesis, the formation
of norbelladine, remains unresolved. There are now plenty of
transcriptomic resources for AA biosynthesis across multiple
species, and these will surely lead to the discovery of new
enzyme activities in the near future.203–205
6. Discussion
Numerous alkaloid biosynthetic pathways exist in plants, and
many of these follow the pattern described in this review: amine
and aldehyde accumulate and condense into an iminium,
which is quenched by a nucleophile in a Mannich-like scaffold-
forming reaction. This model of alkaloid biosynthesis high-
lights how plants exploits simple chemical logic to construct
complex molecules.18 It also enables us to gain insight into how
these pathways may have evolved.
6.1. Precursor accumulation
The key requirement for alkaloid biosynthesis is the accumu-
lation, or increased production, of precursors in a location
specic manner. Amine accumulation occurs due to changes in
amino acid or polyamine metabolism. This can be triggered by
gene duplication leading to neofunctionalisation through loss
of feedback inhibition,84 shis in substrate specicity61 or
changes to regulation.206 Complex alkaloids require a second
molecule to accumulate. In the case of aromatic amino acid
derived alkaloids, this is an aldehyde, whereas for polyamine-
derived alkaloids, the accumulating compound is a nucleo-
phile. Aldehydes may be generated directly from accumulating
amino acid precursors (e.g. betalamic acid, 4-HPAA) or may be
co-opted from existing secondary metabolism (e.g. secologa-
nin). Nucleophiles in polyamine-derived alkaloid biosynthesis
have a diverse origin, in secondary metabolism (e.g. polyketides)
or from duplicated pathways (e.g. nicotinic acid).
6.2. Subcellular localisation
To form a specic alkaloid scaffold, the two reacting species must
accumulate in the same subcellular compartment. Whist this
compartment may differ between alkaloid pathways, possible
locations include the peroxisome or vacuole. Accumulating poly-
amines are oxidised into amino aldehydes by promiscuous
peroxisomal CuAOs and form cyclic iminiums. If a nucleophile is
transported to or synthesised in the peroxisome they could react
with the cyclic iminiums prior to export to the cytoplasm.
The vacuole seems a likely location for alkaloid biosynthesis:
accumulating compounds may be sequestered in the vacuole to
prevent cellular damage. Aldehydes for example, are cytotoxic due
to their ability to cross-link DNA or proteins. Alkaloid precursors
and products have been measured at high concentration in the
vacuole.75,207 Furthermore, the Pictet–Spengler reaction in MIA
biosynthesis occurs in the vacuole197 and other enzymes involved
in key scaffold forming steps in alkaloid biosynthesis have vacu-
olar targeting sequences (e.g. NCS, BBL).160,172 Reactive specialised
metabolites are oen sequestered in the vacuole and its acidic
conditions may promote spontaneous reactions.207,208 As the
pathway matures and comes under greater regulation,206 the
reaction may migrate to a different subcellular location.
6.3. Spontaneous reactions
In a cellular environment, two molecules at high concentration
with complementary reactivity may combine spontaneously,
without enzyme catalysis. Spontaneous reactions can lead to
a leap in chemical complexity, as they are not reliant on existing
enzyme mechanisms or substrate constraints. Therefore, new
chemical scaffolds can be formed without the evolution of new
enzyme activities.
Recently the Mannich-like reaction from tropane alkaloid
biosynthesis has been shown to occur without enzyme
Scheme 27 Amaryllidaceae alkaloid biosynthesis. (A) Entry point into the Amaryllidaceae alkaloid biosynthesis by condensation and reduction. (B)
Reaction catalysed by noroxamartidine reductase.
This journal is © The Royal Society of Chemistry 2020 Nat. Prod. Rep.
















































































































catalysis.153 In other polyamine-derived alkaloids, evidence for
spontaneous quenching can be found in the presence of
multiple stereoisomers in planta162 or in biomimetic reac-
tions.143,144,164 Furthermore, this non-catalysed reaction can
account for the modularity of nucleophile and electrophile. An
exemplar of the modularity is tropane and nicotine alkaloid
biosynthesis in the Solanaceae: both require N-methylpyr-
ollinium but utilise nucleophiles of different origins. Notably,
the gene duplications required to cause accumulation of N-
methylpyrollinium appeared prior to the ancestor of the Sol-
anaceae, whilst the genes required for the formation of nico-
tinic acid-like nucleophile only arose in the Nicotiana genus.
Therefore, specic taxa have evolved different ‘solutions’ to an
abundance of N-methylpyrollinium by accumulating different
nucleophiles that react with the iminium and form bioactive
compounds. Similarly, different electrophiles can also react
with the same nucleophile, such as the homologous tropane
and granatane alkaloids derived from 3-oxoglutaric acid plus N-
methylpyrollinium or D1-piperideine respectively.
Iminium formation in betalain biosynthesis is spontaneous
and does not involve enzyme catalysis.150 The Pictet–Spengler
reactions of MIA and BIA are enzyme catalysed, but they have
a low activation barrier and can occur in relatively mild aqueous
conditions.72,209 With sufficient concentration of precursors, the
Pictet–Spengler reaction can occur within a cell without
a specic catalyst.169 Therefore, it is conceivable that the Pictet–
Spengler step emerged prior to the origins of a corresponding
Pictet–Spenglerase.
6.4. Enzyme evolution
If the new compound formed from a spontaneous reaction
confers an advantage—through the development of new
bioactivities or reduction in cellular toxicity—an enzymemay be
recruited to enhance its reaction rate or provide stereo-
selectivity. Therefore, a reaction that occurs spontaneously and
rapidly in vitromay still have an associated enzyme in vivo. This
has been highlighted recently with the identication of
enzymes for steps in BIA biosynthesis previously thought to be
spontaneous.176,177
Enzymes that have evolved to catalyse a “spontaneous”
reaction are somewhat unusual in that they oen evolve from
protein families with no obvious connection to the reaction or
pathway (e.g. NCS, SS). In structurally related alkaloid pathways
with independent origins, enzymes catalysing similar “sponta-
neous” steps would not be orthologous and could have evolved
from a variety of protein starting points: they may not be easy to
identify through homology. In this sense these enzymes have
similarities to the [4 + 2]-cyclases, which are from diverse
protein families.210
It is possible that proteins have evolved to inuence the
stereochemical course of the reaction without necessarily cata-
lysing it. Such scaffolding proteins are sometimes referred to as
dirigent proteins, and have been identied in lignin211 and iri-
doid biosynthesis.212 Although none has been identied in
alkaloid biosynthesis to date, they could account for the enan-
tiomeric enrichment observed in polyamine-derived alkaloids.
6.5. Pathway evolution
This model of alkaloid biosynthesis suggests that the key factor
in the evolution of new alkaloids are modications to existing
primary and secondary metabolism, and not the emergence of
a new enzyme activity. Scaffold-forming enzymes have been
considered crucial for catalysing the rst-committed step into
alkaloid pathways. However, at least in the early stages of
Scheme 28 Hypothetical biosynthesis of nitrarine fromNitraria. This route highlights how the themes of amine/aldehyde accumulation, iminium
formation and Mannich-like reactions are modular and lead to chemical complexity.164,217
Nat. Prod. Rep. This journal is © The Royal Society of Chemistry 2020
















































































































alkaloid pathway evolution, such steps may occur without
enzyme catalysis.
This ts with a general model of metabolite-enzyme coevo-
lution where enzymes catalysing rate-limiting steps are the rst
to be recruited into a new pathway.213 When the scaffold-
forming step has a low energy barrier, it will not be rate-
limiting. Instead, the upstream steps that determine the
concentration of precursors will limit ux, and enzymes
boosting these will emerge rst. Even some downstream steps
with high energy barriers—such as those catalysed by methyl-
transferases, cytochrome P450 and dehydrogenases—may be
established before an enzyme catalysing the scaffold-forming
step emerges. A combination of phylogenetics and biochem-
istry may be able to interrogate the relative timings of enzyme
evolution in a pathway.
7. Conclusion
Methods for the discovery and characterisation of enzymes
from plant specialised metabolism have reached maturity,4 and
we will continue to see rapid progress in the elucidation of
alkaloid biosynthesis.214 These discoveries will feed into
synthetic biology andmetabolic engineering, and consequently,
the yields and variety of alkaloids available from heterologous
production methods will increase.12,215 Phylogenomic
approaches are beginning to reveal the evolutionary origins of
specialised metabolism,216 and with ever increasing sequence
data, these can be applied to alkaloid producing plants.
Furthermore, investigations into aspects of alkaloid biosyn-
thesis such as how ux is channelled from primary metabo-
lism,39 how promoters have evolved206 and how pathways are
compartmentalised197,207 will help reveal how alkaloid biosyn-
thesis is integrated into a complete cellular context.
Alkaloids have fascinated scientists for centuries due to their
structural intricacies and profound bioactivities. Despite these
complexities, alkaloid formation is largely governed by a simple
and modular chemical logic, centred around iminium reactivity
(e.g. Scheme 28).18,164,217 The ability of nature to generate functional
and diverse molecules from simple physical principles will provide
inspiration for chemists and biologists for many decades to come.
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7 H. W. Nützmann, A. Huang and A. Osbourn, New Phytol.,
2016, 211, 771–789.
8 S. A. Kautsar, H. G. Suarez Duran, K. Blin, A. Osbourn and
M. H. Medema, Nucleic Acids Res., 2017, 45, W55–W63.
9 H. Kries and S. E. O'Connor, Curr. Opin. Chem. Biol., 2016,
31, 22–30.
10 R. Roddan, J. M. Ward, N. H. Keep and H. C. Hailes, Curr.
Opin. Chem. Biol., 2020, 55, 69–76.
11 S. Brown, M. Clastre, V. Courdavault and S. E. O'Connor,
Proc. Natl. Acad. Sci. U. S. A., 2015, 112, 3205–3210.
12 S. Galanie, K. Thodey, I. J. Trenchard, M. F. Interrante and
C. D. Smolke, Science, 2015, 349, 1095–1100.
13 S. Li, Y. Li and C. D. Smolke, Nat. Chem., 2018, 10, 395–404.
14 K. M. Frick, L. G. Kamphuis, K. H. M. Siddique, K. B. Singh
and R. C. Foley, Front. Plant Sci., 2017, 8, 87.
15 S. Funayama and G. A. Cordell, Alkaloids, Elsevier, 2015.
16 M. Wink, Alkaloids, 1993, 43, 1–118.
17 M. F. Roberts, D. Strack and M. Wink, Biosynthesis of
Alkaloids and Betalains, 2010, vol. 40.
18 G. Anarat-Cappillino and E. S. Sattely, Curr. Opin. Plant
Biol., 2014, 19, 51–58.
19 B. Daniel, B. Konrad, M. Toplak, M. Lahham,
J. Messenlehner, A. Winkler and P. Macheroux, Arch.
Biochem. Biophys., 2017, 632, 88–103.
20 S. Larsson and N. Rønsted, Curr. Top. Med. Chem., 2014, 14,
274–289.
21 S. Bunsupa, M. Yamazaki and K. Saito, Mini-Rev. Med.
Chem., 2017, 17, 1002–1012.
22 N. Kim, O. Estrada, B. Chavez, C. Stewart and J. C. D'Auria,
Molecules, 2016, 21, 1–25.
23 A. Singh, I. M. Menéndez-Perdomo and P. J. Facchini,
Phytochem. Rev., 2019, 240, 19–32.
24 J. M. Hagel and P. J. Facchini, Plant Cell Physiol., 2013, 54,
647–672.
25 Z. Jin and G. Yao, Nat. Prod. Rep., 2019, 36, 1462–1488.
26 T. Hotchandani and I. Desgagné-Penix, Curr. Top. Med.
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